Stock CN, Chillon CJ, Hernandez CL, Moro FM, et al. Combination of disease burden before allogeneic transplantation and early post-transplant minimal residual disease predicts survival in patients with acute myeloid leukemia. Ann Hematol 2025 Apr 25. doi: 10.1007/s00277-025-06325.
PMID: 40278922